Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FOCUS
NCT07463950Phase 4Terminated
- Sponsor
- Medical University of Vienna
- Start
- Jan 2026
- Primary completion
- May 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of cyclosporine 2% ophthalmic solution in dry eye disease (DED), sponsored by Medical University of Vienna. Started Jan 2026; status: terminated.
02
Drugs
cyclosporine 2% ophthalmic solution
03
Conditions
dry eye disease (DED)
Beyond the preview
Go deeper on NCT07463950.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07463950.